Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

ASSTON PHARMACEUTICALS LIMITED

Healthcare › Pharmaceuticals & Biotechnology
₹141.16
at close · 27 Oct 2026
▲ 8.16 (+6.14%)

Latest filings

  1. RTA compliance certificate under SEBI Reg 74(5) for Q2 FY26 filed · Compliance
  2. Registered office shifted within Navi Mumbai · General
  3. Registered Office Shift Within Navi Mumbai - Effective 15 Oct 2026 · General
All filings ↓
Ask Nexa about ASSTON PHARMACEUTICALS LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE.

Market Cap
₹120 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
12.3%▲
ROCE (FY26)
ROE 9.9% · margin 21.8%
Leverage
0.13·
Debt / Equity · low
Net debt ₹3.82 Cr
Moves on a normal day
2.34%·
Median daily move
Last 234 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#147/158
P/B#83/163
ROCE#91/183
ROE#82/166
Debt / Equity#79/166
EBITDA margin#78/165

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Nothing stands out in the filed numbers.
Concerns
Heavy working capital — 453 days of cash tied up

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from ASSTON PHARMACEUTICALS LIMITED's filed financials and exchange disclosures

What does ASSTON PHARMACEUTICALS LIMITED do?

ASSTON PHARMACEUTICALS LIMITED is a Pharmaceuticals & Biotechnology company listed on BSE.

Does ASSTON PHARMACEUTICALS LIMITED pay a dividend?

Not in the latest reported year — ASSTON PHARMACEUTICALS LIMITED's dividend payout for FY26 was nil.

Is ASSTON PHARMACEUTICALS LIMITED debt-free?

No. It reported borrowings of ₹5.11 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹3.82 Cr after cash. Debt stands at 0.13× equity. That is lower than 53% of its 166 Pharmaceuticals peers.

How much does the ASSTON PHARMACEUTICALS LIMITED share price move in a day?

On a typical session ASSTON PHARMACEUTICALS LIMITED moves 2.34% — that is the median absolute close-to-close move across its last 234 trading days. MarketPing measures each filing's price reaction against it.

Where can I track ASSTON PHARMACEUTICALS LIMITED's announcements?

Every NSE and BSE filing by ASSTON PHARMACEUTICALS LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.